查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球肺功能測試市場
市場調查報告書
商品編碼
1296934

2023-2030年全球肺功能測試市場

Global Pulmonary Function Testing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 105 Pages | 商品交期: 2-3個工作天內

價格

在預測期內，全球肺功能測試市場預計將以8.3%的年復合成長率成長。全球肺功能檢測系統的市場需求受到肺部相關疾病發病率上升、肺功能檢測系統的技術進步和職業性肺部疾病的推動。例如，2023年4月，阿桑醫療中心（AMC）開發了一種人工智慧肺部測試設備，可以根據電腦斷層掃描（CT）測試結果預測肺部功能，準確率達到90%以上。這種算法能夠根據CT掃描結果識別肺功能下降的患者。此外，該人工智慧被發現可以根據測量強制生命力（FVC），和一秒內強制呼氣量（FEV1）來預測高風險指標，準確率約為85%。

此外，公共和私人組織的資金增加將進一步推動市場成長。 2023年4月，諾亞醫療籌集了1.5億美元，以幫助建立其銀河系統背後的商業引擎，旨在使用一次性探針進行導航式肺部支氣管鏡檢查。銀河系統等下一代機器人平台正在填補程序上的空白，以提供卓越的臨床價值，更好地滿足客戶的需求。該系統還配備了諾亞所稱的Tool-in-Lesion Tomo+技術，或TiLT+，它為外科醫生提供即時、圖像引導的更新，以幫助確認活體組織切片工具何時完全進入其目標組織。

目錄

第一章：報告摘要

  • 研究方法和工具
  • 市場細分
    • 按領域分類
    • 按地理區域分類

第二章：市場概述和洞察力

  • 報告的範圍
  • 分析師的洞察力和當前的市場趨勢
    • 主要發現
    • 建議
    • 總結
  • 規則和條例

第三章：競爭格局

  • 主要公司分析
    • Koninklijke Philips NV
    • ResMed Inc.
    • Thermo Fisher Scientific Inc.
  • 關鍵戰略分析

第四章：市場細分

  • 按設備類型分類的全球肺功能測試市場
    • 手持式
    • 台式
  • 按產品類型分類的全球肺功能測試市場
    • 肺量計
    • 肺容積測試
    • 動脈血氣測試
    • 脈搏血氧儀
    • 其他（最大自願通氣）。
  • 全球肺功能測試市場的應用
    • 呼吸道感染
    • 哮喘
    • 石棉病
    • 腫瘤
    • 肉毒桿菌病
    • 其他（胸部手術）。
  • 按終端用戶分類的全球肺功能測試市場
    • 醫院
    • 臨床實驗室
    • 診斷學實驗室

第五章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 亞太其他地區
  • 世界其他地區

第六章：公司簡介

  • Carestream Health.
  • Carestream Health.
  • Chest MI, Inc.
  • Cosmed Srl
  • Ganshorn Medizin Electronic GmbH
  • Koko, Llc
  • Medical Electronic Corp.
  • Medical Equipment Europe GmbH
  • Mgc Diagnostics Corp.
  • Minato Medical Science Co.
  • Morgan Scientific Inc.
  • ndd Medical Technologies, Inc.
  • Omron Healthcare, Inc.
  • PulmOne USA Inc.
  • Vyaire Medical, Inc.
Product Code: OMR2027409

Title: Global Pulmonary Function Testing Market Size, Share & Trends Analysis Report by Device Type (Handheld, and Tabletop), by Product Type (Spirometry, Lung Volume Testing, Arterial Blood Gas Testing, Pulse Oximetry, and Others (Maximal Voluntary Ventilation)), by Application (Respiratory Infections, Asthma, Asbestosis, Tumors, Sarcoidosis, and Others (chest surgery), and by End User (Hospitals, Clinical Laboratories, and Diagnostics Laboratories) Forecast Period (2023-2030).

The global pulmonary function testing market is anticipated to grow at a CAGR of 8.3% during the forecast period. Global pulmonary function testing systems market demand is fueled by the rising incidence of lung-related disorders, technological advancements in pulmonary function testing systems and occupational lung diseases. For instance, in April 2023, Asan Medical Center (AMC) developed an artificial intelligence lung testing device that predicts lung function based on computed tomography (CT) test results with an accurate rate of 90% or higher. This algorithm is capable of identifying patients with decreased lung function based on CT scans. Moreover, the AI was found to predict the high-risk indicator based on both measurements forced vital capacity (FVC), and forced expiratory volume in one second (FEV1) with approximately 85% accuracy.

In addition, increasing funding by public and private organizations will further propel the market growth. In April 2023, Noah Medical raised $150 million to help build a commercial engine behind its Galaxy system, designed to perform navigated lung bronchoscopies using disposable probes. Next-generation robotics platforms such as Galaxy System are filling procedural gaps to provide superior clinical values to better serve customers' needs. The system is also equipped with what Noah has dubbed Tool-in-Lesion Tomo+ technology, or TiLT+, which provides surgeons with real-time, image-guided updates to help confirm when the biopsy tool is fully within its target tissue.

Segmental Outlook

The global pulmonary function testing market is segmented based on its device type, product type, application, and end user. Based on device type, the market is bifurcated into handheld, and tabletop. Based on product type, the market is categorized into spirometry, lung volume testing, arterial blood gas testing, pulse oximetry, and others. Based on application, the market is divided into respiratory infections, asthma, asbestosis, tumors, sarcoidosis, and others. Based on end user, the market is segmented into hospitals, clinical laboratories, and diagnostics laboratories. Based on product type, the spirometry segment holds a significant market share. Increasing the use of spirometry for detecting lung infection is driving the segment growth. Spirometry tells whether the patient has a breathing problem caused by an obstruction of air that's left in his or her lungs or a restriction of air entering the lung.

The Sarcoidosis Segment Holds a Significant Share in the Global Pulmonary Function Testing Market

Based on application, the sarcoidosis segment is projected to witness significant growth during the forecast period. An increase in awareness regarding sarcoidosis diseases, along with extensive funding provided by regulatory bodies positively influences the market growth. For instance, in October 2022, Xentria has raised $25 million in funding to further the development of XTMAB-16, its experimental antibody therapy for sarcoidosis. With this funding, the company advance the Xentria pipeline and execute against the goal of developing critical therapeutics for patients in need. Furthermore, according to the Foundation for Sarcoidosis Research, in 2021 nearly 175,000 people in the US have sarcoidosis, with an estimated 1.2 million individuals living with the disease globally.

Regional Outlooks

The global pulmonary function testing market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Europe region is projected to hold a significant share in the pulmonary function testing market. A considerable increase in the incidence of chronic obstructive pulmonary diseases and asthma cases, along with numerous campaigns organized by regulatory bodies to create awareness among the people, drive the market growth.

Global Pulmonary Function Testing Market Growth, by Region 2023-2030

Source: OMR Analysis

The North America Region Holds a Prominent Market Share in the Global Pulmonary Function Testing Market

Based on region, North America is projected to have the highest CAGR over the forecast period. Rising technological advancements in diagnostics, well-developed pulmonary healthcare infrastructure, increasing prevalence of chronic respiratory diseases, are the primary factor that boost the market growth. For instance, in September 2022, Optellum, AI Lung Cancer diagnosis innovator, secures $14million Series A funding to accelerate expansion. This first-of-a-kind platform help physicians identify and track at-risk patients, and optimally diagnose the signs of lung cancer early, so treatment can be started sooner for patients with tumors, and invasive procedures such as biopsies on benign lesions can be minimized.

Market Players Outlook

The major companies serving the global pulmonary function testing market include Ganshorn Medizin Electronic GmbH, KoKo, LLC, Koninklijke Philips N.V., Medical Electronic Corp., NDD Medical Technologies, and others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2020, NDD Medical Technologies (ndd), introduced single patient-use, inline filters for its lung function testing devices in response to COVID-19. Ensuring added safety, the filters complement NDD's revolutionary, highly portable EasyOne spirometry range, including EasyOne Air, Pro, and Pro LAB. Ndd's popular spirometers are of the most sensitive devices, delivering reliable, real-time lung function results and enabling specialists diagnoses of chronic lung diseases, even at the point of care.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global pulmonary function testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Koninklijke Philips N.V.
      • 3.1.1.1. Overview
      • 3.1.1.2. Financial Analysis
      • 3.1.1.3. SWOT Analysis
      • 3.1.1.4. Recent Developments
    • 3.1.2. ResMed Inc.
      • 3.1.2.1. Overview
      • 3.1.2.2. Financial Analysis
      • 3.1.2.3. SWOT Analysis
      • 3.1.2.4. Recent Developments
    • 3.1.3. Thermo Fisher Scientific Inc.
      • 3.1.3.1. Overview
      • 3.1.3.2. Financial Analysis
      • 3.1.3.3. SWOT Analysis
      • 3.1.3.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Pulmonary Function Testing Market by Device Type
    • 4.1.1. Handheld
    • 4.1.2. Tabletop
  • 4.2. Global Pulmonary Function Testing Market by Product Type
    • 4.2.1. Spirometry
    • 4.2.2. Lung Volume Testing
    • 4.2.3. Arterial Blood Gas Testing
    • 4.2.4. Pulse Oximetey
    • 4.2.5. Others (Maximal Voluntary Ventilation)
  • 4.3. Global Pulmonary Function Testing Market by Application
    • 4.3.1. Respiratory Infections
    • 4.3.2. Asthma
    • 4.3.3. Asbestosis
    • 4.3.4. Tumors
    • 4.3.5. Sarcoidosis
    • 4.3.6. Others (Chest Surgery)
  • 4.4. Global Pulmonary Function Testing Market by End User
    • 4.4.1. Hospitals
    • 4.4.2. Clinical Laboratories
    • 4.4.3. Diagnostics Laboratories

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. US
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Carestream Health.
  • 6.2. Carestream Health.
  • 6.3. Chest M.I., Inc.
  • 6.4. Cosmed Srl
  • 6.5. Ganshorn Medizin Electronic GmbH
  • 6.6. Koko, Llc
  • 6.7. Medical Electronic Corp.
  • 6.8. Medical Equipment Europe GmbH
  • 6.9. Mgc Diagnostics Corp.
  • 6.10. Minato Medical Science Co.
  • 6.11. Morgan Scientific Inc.
  • 6.12. ndd Medical Technologies, Inc.
  • 6.13. Omron Healthcare, Inc.
  • 6.14. PulmOne USA Inc.
  • 6.15. Vyaire Medical, Inc.

LIST OF TABLES

  • 1. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL HANDHELD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL TABLETOP PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 5. GLOBAL PULMONARY SPIROMETRY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL PULMONARY LUNG VOLUME FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL PULMONARY ARTERIAL BLOOD GAS FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL PULSE OXIMETRY PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL OTHERS PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 11. GLOBAL PULMONARY FUNCTION TESTING FOR RESPIRATORY INFECTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL PULMONARY FUNCTION TESTING FOR ASTHMA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL PULMONARY FUNCTION TESTING FOR ASBESTOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL PULMONARY FUNCTION TESTING FOR TUMORS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL PULMONARY FUNCTION TESTING FOR SARCOIDOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL PULMONARY FUNCTION TESTING FOR OTHERS (CHEST SURGERY) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 18. GLOBAL PULMONARY FUNCTION TESTING IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. GLOBAL PULMONARY FUNCTION TESTING IN CLINICAL LABORATRIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 20. GLOBAL PULMONARY FUNCTION TESTING IN DIAGNOSTICS LABORATRIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 21. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 25. NORTH AMERICAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 26. NORTH AMERICAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 27. EUROPEAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 28. EUROPEAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 29. EUROPEAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 30. EUROPEAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 31. EUROPEAN PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 32. ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 33. ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 34. ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE , 2022-2030 ($ MILLION)
  • 35. ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 36. ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 37. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 38. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022-2030 ($ MILLION)
  • 39. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
  • 40. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 41. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL HANDHELD PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL TABLETOP PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022 VS 2030 (%)
  • 5. GLOBAL PULMONARY SPIROMETRY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL PULMONARY LUNG VOLUME FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL PULMONARY ARTERIAL BLOOD GAS FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL PULSE OXIMETRY PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL OTHERS PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
  • 11. GLOBAL PULMONARY FUNCTION TESTING FOR RESPIRATORY INFECTIONS MARKET RESEARCH AND ANALYSIS BY REGION,2022 VS 2030 (%)
  • 12. GLOBAL PULMONARY FUNCTION TESTING FOR ASTHMA MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL PULMONARY FUNCTION TESTING FOR ASBESTOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL PULMONARY FUNCTION TESTING FOR TUMORS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL PULMONARY FUNCTION TESTING FOR SARCOIDOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL PULMONARY FUNCTION TESTING FOR OTHERS (CHEST SURGERY) MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL PULMONARY FUNCTION TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022 VS 2030 (%)
  • 18. GLOBAL PULMONARY FUNCTION TESTING IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 19. GLOBAL PULMONARY FUNCTION TESTING IN CLINICAL LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 20. GLOBAL PULMONARY FUNCTION TESTING IN DIAGNOSTICS LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 21. US PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CANADA PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. UK PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. FRANCE PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. GERMANY PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. ITALY PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. SPAIN PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. ROE PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. INDIA PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. CHINA PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. JAPAN PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. REST OF THE WORLD PULMONARY FUNCTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)